Literature DB >> 16307274

Familial Mediterranean fever and ankylosing spondylitis in a patient with juvenile idiopathic arthritis: A case report and review of the literature.

Işik Keleş1, Gülümser Aydin, Aliye Tosun, Elem Inal, Hatice Keleş, Sevim Orkun.   

Abstract

The association of familial Mediterranean fever (FMF) with juvenile idiopathic arthritis (JIA) or ankylosing spondylitis (AS), most commonly with negative HLA-B27 antigen, was described in several previous reports, although the pathogenic mechanism of this association still remains unknown. Herein we report an uncommon association of FMF with HLA-B27 positive AS as an occasional coincidence in a patient who had been diagnosed as having JIA 23 years previously.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16307274     DOI: 10.1007/s00296-005-0080-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  14 in total

1.  Familial Mediterranean fever with HLA B-27 positive ankylosing spondylitis in a young Armenian man.

Authors:  P Kaushik; N I el-Sobkie; D Shehab; A N Malaviya
Journal:  Clin Exp Rheumatol       Date:  1999 May-Jun       Impact factor: 4.473

Review 2.  The place of juvenile onset spondyloarthropathies in the Durban 1997 ILAR classification criteria of juvenile idiopathic arthritis. International League of Associations for Rheumatology.

Authors:  Rubén Burgos-Vargas; Martín Rudwaleit; Joachim Sieper
Journal:  J Rheumatol       Date:  2002-05       Impact factor: 4.666

3.  International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.

Authors:  Ross E Petty; Taunton R Southwood; Prudence Manners; John Baum; David N Glass; Jose Goldenberg; Xiaohu He; Jose Maldonado-Cocco; Javier Orozco-Alcala; Anne-Marie Prieur; Maria E Suarez-Almazor; Patricia Woo
Journal:  J Rheumatol       Date:  2004-02       Impact factor: 4.666

4.  Arthritis in familial Mediterranean fever.

Authors:  I Uthman; R A Hajj-Ali; T Arayssi; A F Masri; F Nasr
Journal:  Rheumatol Int       Date:  2001-05       Impact factor: 2.631

5.  The musculoskeletal manifestations of familial Mediterranean fever in children genetically diagnosed with the disease.

Authors:  R Brik; M Shinawi; L Kasinetz; R Gershoni-Baruch
Journal:  Arthritis Rheum       Date:  2001-06

6.  Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever.

Authors:  Y Shinar; A Livneh; P Langevitz; N Zaks; I Aksentijevich; D E Koziol; D L Kastner; M Pras; E Pras
Journal:  J Rheumatol       Date:  2000-07       Impact factor: 4.666

7.  Seronegative spondyloarthropathy in familial Mediterranean fever.

Authors:  P Langevitz; A Livneh; D Zemer; J Shemer; M Pras
Journal:  Semin Arthritis Rheum       Date:  1997-10       Impact factor: 5.532

8.  Severe outcome of juvenile idiopathic arthritis (JIA) associated with familial Mediterranean fever (FMF).

Authors:  M Rozenbaum; I Rosner
Journal:  Clin Exp Rheumatol       Date:  2004 Jul-Aug       Impact factor: 4.473

Review 9.  Toward an understanding of the long-term outcome of juvenile idiopathic arthritis.

Authors:  A Ravelli
Journal:  Clin Exp Rheumatol       Date:  2004 May-Jun       Impact factor: 4.473

Review 10.  Early predictors of outcome in juvenile idiopathic arthritis.

Authors:  A Ravelli; A Martini
Journal:  Clin Exp Rheumatol       Date:  2003 Sep-Oct       Impact factor: 4.473

View more
  8 in total

Review 1.  Familial Mediterranean fever and seronegative arthritis.

Authors:  Nurullah Akkoc; Ahmet Gul
Journal:  Curr Rheumatol Rep       Date:  2011-10       Impact factor: 4.592

2.  The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis.

Authors:  Timuçin Kaşifoğlu; Cüneyt Calişir; Döndü U Cansu; Cengiz Korkmaz
Journal:  Clin Rheumatol       Date:  2008-09-16       Impact factor: 2.980

3.  The rate and significance of Mediterranean fever gene mutations in patients with ankylosing spondylitis: a three-month, longitudinal clinical study.

Authors:  Muhammet Cinar; Ayhan Dinc; Ismail Simsek; Hakan Erdem; Bayram Koc; Salih Pay; Yusuf Tunca; Selim Kilic; Davud Gul
Journal:  Rheumatol Int       Date:  2008-07-03       Impact factor: 2.631

4.  Intramuscular gold for the treatment of seronegative spondyloarthropathy associated with familial Mediterranean fever.

Authors:  Mehmet D Demirag; Mehmet A Ozturk; Berna Goker; Seminur Haznedaroglu
Journal:  Rheumatol Int       Date:  2008-07-01       Impact factor: 2.631

5.  Familial mediterranean fever unusually coexisted in an ankylosing spondylitis patient. MEFV mutation has any role?

Authors:  Iltekin Duman; Birol Balaban; Ilknur Tugcu; Kemal Dincer
Journal:  Rheumatol Int       Date:  2006-12-06       Impact factor: 3.580

6.  Targeting chondrocytes for arresting bony fusion in ankylosing spondylitis.

Authors:  Fenli Shao; Qianqian Liu; Yuyu Zhu; Zhidan Fan; Wenjun Chen; Shijia Liu; Xiaohui Li; Wenjie Guo; Gen-Sheng Feng; Haiguo Yu; Qiang Xu; Yang Sun
Journal:  Nat Commun       Date:  2021-11-11       Impact factor: 14.919

7.  Coexisting Diseases in Patients with Familial Mediterranean Fever.

Authors:  Farhad Salehzadeh; Afsaneh Enteshari Moghaddam
Journal:  Open Access Rheumatol       Date:  2020-05-28

Review 8.  Autoinflammatory Diseases and Physical Therapy.

Authors:  Eda Gurcay; Aysen Akinci
Journal:  Mediterr J Rheumatol       Date:  2017-12-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.